Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

NeuroBo Pharmaceuticals, Inc

+1 (857) 702-9600
Website

Advertisement

Advertisement

545 Concord Ave Ste 210
Cambridge, MA 02138
+1 (857) 702-9600
https://www.neurobopharma.com

NeuroBo Pharmaceuticals, Inc. is a company based in Cambridge that provides comprehensive information about its business to stockholders, potential investors, and financial analysts through its Investor Relations website.

With a focus on transparency and communication, NeuroBo Pharmaceuticals, Inc. aims to keep stakeholders informed and engaged with the latest updates and developments in the company's operations and performance.

Generated from their website's infomation

Also at this address

Dr. Marsha Vannicelli

Toland, Daniel E Agt

Sony Biosciences America

Moye, Lauren, Psyd

Find related places

Clinic

Clinic

Therapy

Therapy

Own this business?
Claim it
See a problem?

You might also like

Sizes, Drugs acting on the respiratory system, Business services, nec, nec

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Drugs acting on the respiratory system, Blood derivatives, Real estate managers

C4T Securities Corporation

C4 Therapeutics, Inc. is a biotechnology company based in Watertown, MA, specializing in targeted protein degradation. Their innovative approach, known as Targeted Protein Degradation (TPD), aims to develop a new generation of medicines for treating various diseases. Through their TORPEDO platform and focus on target selection, C4 Therapeutics is dedicated to transforming lives by degrading disease-causing proteins. With a strong leadership team, board of directors, and scientific advisory board, C4 Therapeutics is committed to advancing their pipeline of therapies, including CFT7455, CFT1946, and CFT8919. They also collaborate with industry partners such as Roche, Biogen, Betta Merck, and others to further their research and development efforts. At C4 Therapeutics, their values, people, and dedication to scientific progress drive their mission to revolutionize the treatment of diseases through targeted protein degradation.Generated from the website
Sizes, Drugs acting on the respiratory system, Vitamin, nutrient, and hematinic preparations for human use

Akebia Therapeutics, Inc

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation
United States›Massachusetts›Cambridge›NeuroBo Pharmaceuticals, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell